Imatinib is a tyrosine kinase inhibitor with antineoplastic activity. It binds to an intracellular pocket located within tyrosine kinases (TK).
更新時(shí)間:2023-07-12
廠商性質(zhì):代理商
色瑞替尼 Ceritinib Ceritinib, also known as LDK378, is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC).
更新時(shí)間:2023-07-12
廠商性質(zhì):代理商
克唑替尼 Crizotinib Crizotinib, also known as PF-02341066, is an orally bioavailable agent belonging to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors
更新時(shí)間:2023-07-12
廠商性質(zhì):代理商
厄洛替尼/埃羅替尼 Erlotinib Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved.
更新時(shí)間:2023-07-12
廠商性質(zhì):代理商
Gefitinib, also known as ZD1839, is an anilinoquinazoline with antineoplastic activity. It inhibits the catalytic activity of numerous tyrosine kinases.
更新時(shí)間:2023-07-12
廠商性質(zhì):代理商